Clinical Trials Logo

Clinical Trial Summary

Poly-unsaturated fatty acids (PUFAs) represent a component of lipids that covers a relevant role in human diet and biological functions such as provision of energy, functionality of cell membranes and tissue metabolism. Fatty acids carbon chains can be saturated (with no presence of double bonds) or unsaturated (with one or more double bonds). PUFAs fall into the unsaturated group, and they can be divided into two classes: omega-3 (n-3) and omega-6 (n-6) fatty acids (FAs). PUFAs are relevant components of cellular membranes, phospholipids, and precursors of eicosanoids, which influence neuronal development and functioning, docosahexaenoic acid (DHA) and arachidonic acid (AA) in fact are involved in cell growth, neural signaling, and gene expression. The main natural dietary source for Eicosapentaenoic acid (EPA) and DHA is fish oil. It has also been shown how the Magnocellular system, which includes the retinal ganglion cells, the lateral geniculate nucleus (for the visual system, while the medial geniculate nucleus would be involved for the auditory system) of the thalamus, the posterior parietal cortex, various areas visual of the cortex and part of the cerebellum, is sensitive to the contribution of fatty acids through nutrition. A deficit related to the Magnocellular system, specialized in the processing of stimuli with high temporal frequencies and low spatial frequencies, in both the visual and auditory modalities, has been proposed as one of the causes of Developmental Dyslexia (DD). According to this hypothesis, an alteration at the magnocellular level would affect reading by hampering temporal processing of the visual signal and would reduce the quality of the phonological representations due to imperfect acoustic analysis of the incoming phonemes. It is therefore possible to hypothesize that supplementation of PUFA in dyslexic children would improve the functions of the M-system and thus create better conditions to the remediation of reading difficulties, especially through remediation programs specifically tapping visual attention and rapid processing of visual stimuli. The remediation program currently used at Scientific Institute (IRCCS) Medea, "Tachidino", based on tachistoscopic, hemisphere-specific stimulation and on training of selective visual-spatial attention, has exactly these characteristics. Hence, the present study aims to test the efficacy of PUFA supplementation before and during treatment with Tachidino.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04287530
Study type Interventional
Source IRCCS Eugenio Medea
Contact Maria Luisa Lorusso, PhD
Phone 031877919
Email marialuisa.lorusso@lanostrafamiglia.it
Status Recruiting
Phase N/A
Start date May 2, 2020
Completion date February 2025

See also
  Status Clinical Trial Phase
Completed NCT04028310 - Developmental Dyslexia and Remediation Methods N/A
Recruiting NCT04122820 - Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). N/A
Enrolling by invitation NCT04323488 - Neural Mechanisms of Successful Intervention in Children With Dyslexia N/A
Completed NCT04041960 - Effects of TBS on Reading in Adult Struggling Readers N/A
Recruiting NCT06261307 - Language Development Deficits and Early Interactive Music Intervention N/A
Recruiting NCT05373576 - Neurofunctional Correlates of the Behavioral Modifications Associated With Tachidino in Children With Developmental Dyslexia N/A
Recruiting NCT06387615 - Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words N/A
Not yet recruiting NCT06403007 - Tackling Two of the Most Important Unresolved Tasks in Reading Intervention N/A